Literature DB >> 29948896

18F-fluorodeoxyglucose use after cardiac transplant: A comparative study of suppression of physiological myocardial uptake.

Renata Christian Martins Felix1, Clécio Maria Gouvea2, Christiane Cigagna Wiefels Reis2, Jacqueline Sampaio Dos Santos Miranda2, Ligia Beatriz Chaves Espinoso Schtruk2, Alexandre Siciliano Colafranceschi2, Cláudio Tinoco Mesquita3.   

Abstract

BACKGROUND: 18F-fluorodeoxyglucose (FDG) has been useful in the evaluation of myocardial inflammatory processes. However, it is challenging to identify them due to physiological 18F-FDG uptake. There are no publications demonstrating the application of FDG in post-transplant rejection in humans yet. The aim of this study is to determine the feasibility of suppression of myocardial FDG uptake in post-transplant patients, comparing three different protocols of preparation.
METHODS: Ten patients after heart transplantation were imaged by FDG associated with three endomyocardial biopsies (EMB), scheduled in the first year after the procedure. Before each imaging, patients were randomized to one of three preparations: (1) hyperlipidic-hypoglycemic diet; (2) fasting longer than 12 hours; and (3) fasting associated with intravenous heparin. All patients would undergo the three methods. FDG images were analyzed using visual analysis scores and relative radiotracer cardiac uptake (RRCU).
RESULTS: The suppression rate of radiotracer activity ranged from 55% to 62%. Visual analysis showed that preparation 3 presented less efficacy in the suppression compared to the others. However, RRCU did not show difference between the preparations.
CONCLUSIONS: Suppression of physiological myocardial FDG uptake after cardiac transplantation is feasible. The usefulness of heparin in the suppression is unclear.

Entities:  

Keywords:  18F-FDG; Heart transplant; PET; myocardial uptake

Mesh:

Substances:

Year:  2018        PMID: 29948896     DOI: 10.1007/s12350-018-1309-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  26 in total

1.  Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.

Authors:  Susan Stewart; Gayle L Winters; Michael C Fishbein; Henry D Tazelaar; Jon Kobashigawa; Jacki Abrams; Claus B Andersen; Annalisa Angelini; Gerald J Berry; Margaret M Burke; Anthony J Demetris; Elizabeth Hammond; Silviu Itescu; Charles C Marboe; Bruce McManus; Elaine F Reed; Nancy L Reinsmoen; E Rene Rodriguez; Alan G Rose; Marlene Rose; Nicole Suciu-Focia; Adriana Zeevi; Margaret E Billingham
Journal:  J Heart Lung Transplant       Date:  2005-06-20       Impact factor: 10.247

2.  Value of FDG-PET/CT using unfractionated heparin for managing primary cardiac lymphoma and several key findings.

Authors:  Ryogo Minamimoto; Miyako Morooka; Kazuo Kubota; Kimiteru Ito; Yoko Masuda-Miyata; Takuya Mitsumoto; Risen Hirai; Osamu Okazaki; Michiaki Hiroe
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

3.  Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake.

Authors:  Chidambaram Natrajan Balasubramanian Harisankar; Bhagwant Rai Mittal; Kanhaiya Lal Agrawal; Mohammed Labeeb Abrar; Anish Bhattacharya
Journal:  J Nucl Cardiol       Date:  2011-07-06       Impact factor: 5.952

4.  Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina.

Authors:  Ian S Rogers; Khurram Nasir; Amparo L Figueroa; Ricardo C Cury; Udo Hoffmann; David A Vermylen; Thomas J Brady; Ahmed Tawakol
Journal:  JACC Cardiovasc Imaging       Date:  2010-04

Review 5.  European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.

Authors:  Luigi P Badano; Marcelo H Miglioranza; Thor Edvardsen; Alexandre Siciliano Colafranceschi; Denisa Muraru; Fernando Bacal; Koen Nieman; Giacomo Zoppellaro; Fabiana G Marcondes Braga; Thomas Binder; Gilbert Habib; Patrizio Lancellotti
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-07-02       Impact factor: 6.875

6.  Suppression of 18F-FDG Myocardial Uptake Using a Fat-Allowed, Carbohydrate-Restricted Diet.

Authors:  Hans Balink; Evelien Hut; Thomas Pol; Freerk-Jan Flokstra; Mark Roef
Journal:  J Nucl Med Technol       Date:  2011-07-27

7.  Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet.

Authors:  Gethin Williams; Gerald M Kolodny
Journal:  AJR Am J Roentgenol       Date:  2008-02       Impact factor: 3.959

8.  Cyclosporine A and Rapamycin induce in vitro cholesteryl ester transfer protein activity, and suppress lipoprotein lipase activity in human plasma.

Authors:  Rita Tory; Kristina Sachs-Barrable; John S Hill; Kishor M Wasan
Journal:  Int J Pharm       Date:  2008-03-27       Impact factor: 5.875

9.  Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis.

Authors:  Lars C Gormsen; Nana Louise Christensen; Elisabeth Bendstrup; Lars Poulsen Tolbod; Søren Steen Nielsen
Journal:  J Nucl Cardiol       Date:  2013-10-17       Impact factor: 5.952

10.  Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis.

Authors:  Michael Soussan; Pierre-Yves Brillet; Hilario Nunes; Gabriel Pop; Matthieu-John Ouvrier; Nicolas Naggara; Dominique Valeyre; Pierre Weinmann
Journal:  J Nucl Cardiol       Date:  2012-11-28       Impact factor: 5.952

View more
  3 in total

1.  Opening the door to noninvasive assessment of cardiac transplant rejection: It's all in the preparation.

Authors:  Pavithra S Jayadeva; Nathan Better
Journal:  J Nucl Cardiol       Date:  2018-06-14       Impact factor: 5.952

2.  Brazilian Society of Cardiology Guideline on Myocarditis - 2022.

Authors:  Marcelo Westerlund Montera; Fabiana G Marcondes-Braga; Marcus Vinícius Simões; Lídia Ana Zytynski Moura; Fabio Fernandes; Sandrigo Mangine; Amarino Carvalho de Oliveira Júnior; Aurea Lucia Alves de Azevedo Grippa de Souza; Bárbara Maria Ianni; Carlos Eduardo Rochitte; Claudio Tinoco Mesquita; Clerio F de Azevedo Filho; Dhayn Cassi de Almeida Freitas; Dirceu Thiago Pessoa de Melo; Edimar Alcides Bocchi; Estela Suzana Kleiman Horowitz; Evandro Tinoco Mesquita; Guilherme H Oliveira; Humberto Villacorta; João Manoel Rossi Neto; João Marcos Bemfica Barbosa; José Albuquerque de Figueiredo Neto; Louise Freire Luiz; Ludhmila Abrahão Hajjar; Luis Beck-da-Silva; Luiz Antonio de Almeida Campos; Luiz Cláudio Danzmann; Marcelo Imbroise Bittencourt; Marcelo Iorio Garcia; Monica Samuel Avila; Nadine Oliveira Clausell; Nilson Araujo de Oliveira; Odilson Marcos Silvestre; Olga Ferreira de Souza; Ricardo Mourilhe-Rocha; Roberto Kalil Filho; Sadeer G Al-Kindi; Salvador Rassi; Silvia Marinho Martins Alves; Silvia Moreira Ayub Ferreira; Stéphanie Itala Rizk; Tiago Azevedo Costa Mattos; Vitor Barzilai; Wolney de Andrade Martins; Heinz-Peter Schultheiss
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

3.  Association between FDG uptake in the right ventricular myocardium and cancer therapy-induced cardiotoxicity.

Authors:  Jahae Kim; Sang-Geon Cho; Sae-Ryung Kang; Su Woong Yoo; Seong Young Kwon; Jung-Joon Min; Hee-Seung Bom; Ho-Chun Song
Journal:  J Nucl Cardiol       Date:  2019-02-04       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.